News

Lenacapavir HIV shot approved in US may enter Canada by 2026; just two injections needed a year
A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...
Safeguarding the windows to the soul
Stay informed on health matters with Zubeda Hamid's newsletter covering cataract surgeries, maternal health, and medical ...
New Atlas11h
MIT's one-shot vaccine could deliver robust protection from HIV
Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...
US approves twice-yearly injection for HIV prevention. What you need to know about lenacapavir
The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...
FDA approves HIV drug based on University of Utah biochemist’s findings
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.
Wasted miracle? Concerns as revolutionary HIV drug approved
The US has approved lenacapavir for HIV prevention. But experts worry that cuts to the health budget will 'squander' the drug's chance of reducing infections.
Boise State Public Radio21h
FDA approves HIV medication Lenacapavir, but it's costly
A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.